Managing Type 2 Diabetes: Evaluating the impact of Cognitive Behavioral Therapy
Phase 3
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
- Registration Number
- CTRI/2024/04/065241
- Lead Sponsor
- Shambhavi Pandey
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed with Type 2 Diabetes for more than a month- Hba1c levels - 6.5 and above.
Exclusion Criteria
Any other types of Diabetes.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Statistical significance will be determined using independent and paired t-tests. A standard deviation of less than 0.005 will be considered significant.Timepoint: On Day 0 of Week 1, we will calculate PSS-10 scores. After the CBT intervention, we will calculate the scores on Day 30 of Week 4.On Day 0 of Week 1, we will calculate PSS-10 scores. After the CBT intervention, we will calculate the scores on Day 30 of Week 4.
- Secondary Outcome Measures
Name Time Method Scales like Generalized Anxiety and Patient Health Questionnaire will have less scoresTimepoint: Better health